Targeting Mirnas for Exosomal Delivery or Cellular Retention
AssigneeJoslin Diabetes Center, Inc.
InventorsC. Ronald Kahn, Ruben Garcia Martin
Life of this patent
Estimating the term…
Abstract
Disclosed herein are exosomal sorting motifs and cellular retention motifs for microRNAs. Methods of use for directing miRNA to exosomes or retaining miRNA in cells are also disclosed.
Claims26
A method for producing exosomes or exosome-like vesicles comprising miRNA in vitro comprising:
- a. modifying a miRNA to include at least one exosomal sorting motif and/or removing any cellular retention motifs;
- b. introducing the modified miRNA into a cell capable of producing an exosome or exosome-like vesicle under conditions that will result in expression of the modified miRNA;
- and
- c. optionally, collecting the produced exosomes or exosome-like vesicles, wherein the exosomal sorting motif is UGUG, GGAG, CAUG, GGCA/G, A/CGGG, CUGG, or CGGGAG and the cell retention motif, if present, is CAGU, ACAG, AUUG, UAGC, or CCCG.
A method of treating a subject in need of gene silencing comprising administering to the subject an exosome, wherein the exosome is produced in vitro by a) modifying a miRNA to include at least one exosomal sorting motif and/or removing any cellular retention motifs, and b) introducing the modified miRNA into an exosome- or exosome-like vesicle producing cell under conditions that will result in expression of the modified miRNA, and collecting the produced exosome comprising the modified miRNA, wherein the exosomal sorting motifs is selected from UGUG, GGAG, CAUG, GGCA/G, A/CGGG, CUGG, and CGGGAG and the cellular retention motif, if present, is selected from CAGU, ACAG, AUUG, UAGC, and CCCG.
A method for retaining miRNA inside a cell in vitro comprising:
- a. modifying a miRNA to include at least one cell retention motif and/or removing any exosomal sorting motifs;
- and
- b. introducing the modified miRNA into a cell capable of producing an exosome or exosome-like vesicle under conditions that will result in expression of the modified miRNA, wherein the cell retention motif is CAGU, ACAG, AUUG, UAGC, or CCCG, and the exosomal sorting motif, if present is UGUG, GGAG, CAUG, GGCA/G, A/CGGG, CUGG, or CGGGAG.
A method for treating a subject in need of gene silencing comprising:
- a. collecting the subject's cells and manipulating them ex vivo to express a miRNA having at least one cellular retention motif and/or removing any exosomal sorting motifs, and
- b. administering the ex vivo manipulated cell comprising the modified miRNA to the same or different subject from which it was collected, wherein the cellular retention motif is selected from CAGU, ACAG, AUUG, UAGC, and CCCG, and the exosomal sorting motif, if present, is selected from UGUG, GGAG, CAUG, GGCA/G, A/CGGG, CUGG, and CGGGAG.
The method of any one of the preceding claims, wherein the cell is an adipocyte, muscle cell, hepatocyte, or vascular endothelial cell.
The method of any one of the preceding claims, wherein the miRNA is any one of the miRNAs of SEQ ID Nos:
- 1-704.
Dependencies are inferred from the claim text.